Overexpression of HOXC6 promotes cell proliferation and migration via MAPK signaling and predicts a poor prognosis in glioblastoma

References

• Weller M, Wick W, Aldape K, et al. Glioma. Nat Rev Dis Primers. 2015;1:15017. doi:10.1038/nrdp.2015.1727188790
   PubMed Web of Science ®Google Scholar
• Ostrom QT, Haley G, Paul F, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006–2010. Neuro Oncol 2013;18(1):204.
   Google Scholar
• Verhaak RG, Hoadley KA, Purdom E, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17:98–110. doi:10.1016/j.ccr.2009.12.02020129251
   PubMed Web of Science ®Google Scholar
• Ostrom QT, Bauchet L, Davis FG, et al. The epidemiology of glioma in adults: a “state of the science” review. Neuro-Oncology. 2014;16:896–913. doi:10.1093/neuonc/nou08724842956
   PubMed Web of Science ®Google Scholar
• Hatoum A, Mohammed R, Zakieh O. The unique invasiveness of glioblastoma and possible drug targets on extracellular matrix. Cancer Manag Res. 2019;11:1843–1855. doi:10.2147/CMAR.S18614230881112
   PubMed Web of Science ®Google Scholar
• Peng H, Li Z, Fu J, Zhou R. Growth and differentiation factor 15 regulates PD-L1 expression in glioblastoma. Cancer Manag Res. 2019;11:2653–2661. doi:10.2147/CMAR.S19209531114328
   PubMed Web of Science ®Google Scholar
• Syed M, Liermann J, Verma V, et al. Survival and recurrence patterns of multifocal glioblastoma after radiation therapy. Cancer Manag Res. 2018;10:4229–4235. doi:10.2147/CMAR.S16595630323678
   PubMed Web of Science ®Google Scholar
• Ren Z, Liang J, Zhang P, Chen J, Wen J. Inhibition of human glioblastoma cell invasion involves PION@E6 mediated autophagy process. Cancer Manag Res. 2019;11:2643–2652. doi:10.2147/CMAR.S20015131015768
   PubMed Web of Science ®Google Scholar
• Du YB, Dong B, Shen LY, Yan WP. The survival predictive significance of HOXC6 and HOXC8 in esophageal squamous cell carcinoma. J Surg Res. 2014;188:442–450. doi:10.1016/j.jss.2014.01.01724525058
   PubMed Web of Science ®Google Scholar
• Liu H, Zhang M, Xu S, et al. HOXC8 promotes proliferation and migration through transcriptional up-regulation of TGFβ1 in non-small cell lung cancer. Oncogenesis. 2018;7(2):1. doi:10.1038/s41389-017-0016-429367650
   PubMedGoogle Scholar
• Watanabe Y, Saito M, Saito K, et al. Upregulated HOXA9 expression is associated with lymph node metastasis in colorectal cancer. Oncol Lett. 2018;15:2756–2762. doi:10.3892/ol.2017.765029435001
   PubMed Web of Science ®Google Scholar
• Quagliata L, Quintavalle C, Lanzafame M, et al. High expression of HOXA13 correlates with poorly differentiated hepatocellular carcinomas and modulates sorafenib response in in vitro models. Lab Invest. 2017;98(1):95. doi:10.1038/labinvest.2017.10729035381
   PubMed Web of Science ®Google Scholar
• Li BIN, Jin H, Yu Y, Gu CHAO, Zhou X, Zhao N. 1042 human homeobox gene (HOX) A10 is overexpressed in human ovarian clear cell adenocarcinoma and correlates with poor survival. Int J Gynecol Cancer. 2010;7:99.
   Google Scholar
• Tsuboi M, Taniuchi K, Shimizu T, Saito M, Saibara T. The transcription factor HOXB7 regulates ERK kinase activity and thereby stimulates the motility and invasiveness of pancreatic cancer cells. J Biol Chem. 2017;292:17681. doi:10.1074/jbc.M116.77278028912272
   PubMed Web of Science ®Google Scholar
• Ji-Yeon L, Ho H, Hyo Jung Y, et al. HOXB5 promotes the proliferation and invasion of breast cancer cells. Int J Biol Sci. 2015;11:701–711. doi:10.7150/ijbs.1143125999793
   PubMed Web of Science ®Google Scholar
• Ya-Bing D, Bin D, Lu-Yan S, et al. The survival predictive significance of HOXC6 and HOXC8 in esophageal squamous cell carcinoma. J Surg Res. 2014;188:442–450. doi:10.1016/j.jss.2014.01.01724525058
   PubMed Web of Science ®Google Scholar
• Zhang Q, Jin XS, Yang ZY, Wei M, Liu BY, Gu QL. Upregulated Hoxc6 expression is associated with poor survival in gastric cancer patients. Neoplasma. 2013;60:439–445. doi:10.4149/neo_2013_05723581417
   PubMed Web of Science ®Google Scholar
• Chang SL, Chan TC, Chen TJ, Lee SW, Lin LC, Win KT. HOXC6 overexpression is associated with Ki-67 expression and poor survival in NPC patients. J Cancer. 2017;8:1647–1654. doi:10.7150/jca.1889328775784
   PubMed Web of Science ®Google Scholar
• Chen SW, Zhang Q, Xu ZF, et al. HOXC6 promotes gastric cancer cell invasion by upregulating the expression of MMP9. Mol Med Rep. 2016;14:3261. doi:10.3892/mmr.2016.564027573865
   PubMed Web of Science ®Google Scholar
• Guo YB, Shao YM, Chen J, et al. Effect of overexpression of HOX genes on its invasive tendency in cerebral glioma. Oncol Lett. 2016;11:75. doi:10.3892/ol.2016.409926870170
   PubMed Web of Science ®Google Scholar
• Zhang X, Hamada JA, Takahashi Y, Murai T, Tada M, Moriuchi T. HOXC6 and HOXC11 increase transcription of S100beta gene in BrdU-induced in vitro differentiation of GOTO neuroblastoma cells into schwannian cells. J Cell Mol Med. 2010;11:299–306. doi:10.1111/j.1582-4934.2007.00020.x
   Google Scholar
• Ji M, Feng Q, He G, et al. Silencing homeobox C6 inhibits colorectal cancer cell proliferation. Oncotarget. 2016;7:29216–29227. doi:10.18632/oncotarget.870327081081
   PubMedGoogle Scholar
• Skiriutė D, Steponaitis G, Vaitkienė P, et al. Glioma malignancy-dependent NDRG2 gene methylation and downregulation correlates with poor patient outcome. J Cancer. 2014;5:446–456. doi:10.7150/jca.914024847385
   PubMed Web of Science ®Google Scholar
• Huang Y, Wang H, Lian Y, et al. Upregulation of kinesin family member 4A enhanced cell proliferation via activation of Akt signaling and predicted a poor prognosis in hepatocellular carcinoma. Cell Death Dis. 2018;9:141. doi:10.1038/s41419-018-1111-y29396392
   PubMed Web of Science ®Google Scholar
• Lian YF, Huang YL, Wang JL, et al. Anillin is required for tumor growth and regulated by miR-15a/miR-16-1 in HBV-related hepatocellular carcinoma. Aging (Albany NY). 2018;10:1884–1901. doi:10.18632/aging.10151030103211
   PubMedGoogle Scholar
• Rhodes DR, Shanker KS, Vasudeva M, et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia. 2007;9:166–180. doi:10.1593/neo.0711217356713
   PubMed Web of Science ®Google Scholar
• Riemenschneider MJ, Jeuken JW, Wesseling P, Reifenberger G. Molecular diagnostics of gliomas: state of the art. Acta Neuropathol. 2010;120:567–584. doi:10.1007/s00401-010-0736-420714900
   PubMed Web of Science ®Google Scholar
• Zhang F, Ren CC, Liu L, Chen YN, Yang L, Zhang XA. HOXC6 gene silencing inhibits epithelial-mesenchymal transition and cell viability through the TGF-β/smad signaling pathway in cervical carcinoma cells. Cancer Cell Int. 2018;18(1):204. doi:10.1186/s12935-018-0680-230559605
   PubMedGoogle Scholar
• Kloth JN, Gert Jan F, Jan O, et al. Substantial changes in gene expression of Wnt, MAPK and TNFalpha pathways induced by TGF-beta1 in cervical cancer cell lines. Carcinogenesis. 2005;26:1493–1502. doi:10.1093/carcin/bgi11015878915
   PubMed Web of Science ®Google Scholar
• Chen J, Sheng X, Deng G. HOXC10 up-regulation promotes gastric cancer cell proliferation and metastasis through MAPK pathway. 中国癌症研究：英文版. 2017;29:572–580.
   Google Scholar
• Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med. 2008;359:492–507. doi:10.1056/NEJMra070812618669428
   PubMed Web of Science ®Google Scholar
• Wang J, Liang H, Sun M, et al. Delta-6-desaturase inhibitor enhances radiation therapy in glioblastoma in vitro and in vivo. Cancer Manag Res. 2018;10:6779–6790. doi:10.2147/CMAR.S18560130584371
   PubMed Web of Science ®Google Scholar
• Wang Z, Yu G, Liu Z, et al. Paeoniflorin inhibits glioblastoma growth in vivo and in vitro: a role for the Triad3A-dependent ubiquitin proteasome pathway in TLR4 degradation. Cancer Manag Res. 2018;10:887–897. doi:10.2147/CMAR.S16029229740218
   PubMed Web of Science ®Google Scholar
• Shota T, Louis DN, Curry WT, Batchelor TT, Jorg D. Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end? Nat Rev Clin Oncol. 2013;10:14–26. doi:10.1038/nrclinonc.2012.20423183634
   PubMed Web of Science ®Google Scholar
• Chen Z, Xu N, Zhao C, Xue T, Wu X, Wang Z. Bevacizumab combined with chemotherapy vs single-agent therapy in recurrent glioblastoma: evidence from randomized controlled trials. Cancer Manag Res. 2018;10:2193–2205. doi:10.2147/CMAR.S17332330087578
   PubMed Web of Science ®Google Scholar
• Poulsen HS, Urup T, Michaelsen SR, Staberg M, Villingshoj M, Lassen U. The impact of bevacizumab treatment on survival and quality of life in newly diagnosed glioblastoma patients. Cancer Manag Res. 2014;6:373–387. doi:10.2147/CMAR.S3930625298738
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–674. doi:10.1016/j.cell.2011.02.01321376230
   PubMed Web of Science ®Google Scholar
• Wang YP, Huang LY, Sun WM, et al. Insulin receptor tyrosine kinase substrate activates EGFR/ERK signalling pathway and promotes cell proliferation of hepatocellular carcinoma. Cancer Lett. 2013;337:96–106. doi:10.1016/j.canlet.2013.05.01923693078
   PubMed Web of Science ®Google Scholar
• Chen H, Zhu HR, Yu XN, et al. Overexpressed pepsinogen C is associated with poor prognosis in human hepatocellular carcinoma: a tissue microarray study. Cancer Manag Res. 2019;11:2927–2934. doi:10.2147/CMAR.S19224131114341
   PubMed Web of Science ®Google Scholar
• Changyong E, Yang J, Li H, Li C. LncRNA LOC105372579 promotes proliferation and epithelial-mesenchymal transition in hepatocellular carcinoma via activating miR-4316/FOXP4 signaling. Cancer Manag Res. 2019;11:2871–2879. doi:10.2147/CMAR.S19797931114338
   PubMed Web of Science ®Google Scholar
• Li Y, Jiao Y, Fu Z, Luo Z, Su J, Li Y. High miR-454-3p expression predicts poor prognosis in hepatocellular carcinoma. Cancer Manag Res. 2019;11:2795–2802. doi:10.2147/CMAR.S19665531114333
   PubMed Web of Science ®Google Scholar
• Zhu L, Pan R, Zhou D, Ye G, Tan W. BCL11A enhances stemness and promotes progression by activating Wnt/beta-catenin signaling in breast cancer. Cancer Manag Res. 2019;11:2997–3007. doi:10.2147/CMAR.S19936831114347
   PubMed Web of Science ®Google Scholar
• Philippe B, Philippe A, Ahmad A. New generations of targeted therapies fighting the resistance in solid tumors. Curr Opin Oncol. 2015;27:243. doi:10.1097/CCO.000000000000017525715325
   PubMed Web of Science ®Google Scholar
• Christian R, Giuseppe B, Giovanni S, et al. The role of targeted therapy for gastrointestinal tumors. Expert Rev Gastroenterol Hepatol. 2014;8:875–885. doi:10.1586/17474124.2014.92287024957206
   PubMed Web of Science ®Google Scholar
• Tait DL, Bahrani-Mostafavi Z, Vestal CG, Richardson C, Mostafavi MT. Downregulation of HOXC6 in serous ovarian cancer. Cancer Invest. 2015;33:303–311. doi:10.3109/07357907.2015.104164126046583
   PubMed Web of Science ®Google Scholar
• Kim S. New and emerging factors in tumorigenesis: an overview. Cancer Manag Res. 2015;7:225–239. doi:10.2147/CMAR.S4779726251629
   PubMed Web of Science ®Google Scholar
• Shahruzaman SH, Fakurazi S, Maniam S. Targeting energy metabolism to eliminate cancer cells. Cancer Manag Res. 2018;10:2325–2335. doi:10.2147/CMAR.S16742430104901
   PubMed Web of Science ®Google Scholar
• Tay RY, Wong R, Hawkes EA. Treatment of metastatic colorectal cancer: focus on panitumumab. Cancer Manag Res. 2015;7:189–198. doi:10.2147/CMAR.S7182126150735
   PubMed Web of Science ®Google Scholar
• Valdespino V, Valdespino PM. Potential of epigenetic therapies in the management of solid tumors. Cancer Manag Res. 2015;7:241–251. doi:10.2147/CMAR.S7035826346546
   PubMed Web of Science ®Google Scholar
• Sun Y, Liu WZ, Liu T, Feng X, Yang N, Zhou HF. Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Signal Transduct Res. 2015;35:600–604. doi:10.3109/10799893.2015.103041226096166
   PubMed Web of Science ®Google Scholar
• Kim EK, Choi EJ. Compromised MAPK signaling in human diseases: an update. Arch Toxicol. 2015;89:867–882. doi:10.1007/s00204-015-1472-225690731
   PubMed Web of Science ®Google Scholar
• Guo C, Hou J, Ao S, Deng X, Lyu G. HOXC10 up-regulation promotes gastric cancer cell proliferation and metastasis through MAPK pathway. Chin J Cancer Res. 2017;29:572–580. doi:10.21147/j.issn.1000-9604.2017.06.1229353980
   PubMed Web of Science ®Google Scholar